CLDX
Price
$26.85
Change
+$0.38 (+1.44%)
Updated
Oct 15, 11:13 AM (EDT)
Capitalization
1.76B
20 days until earnings call
Intraday Buy/Sell Signals
ZLDPF
Price
$75.00
Change
-$2.42 (-3.13%)
Updated
Oct 14 closing price
Capitalization
5.4B
Intraday Buy/Sell Signals
Interact to see
Advertisement

CLDX vs ZLDPF

Header iconCLDX vs ZLDPF Comparison
Open Charts CLDX vs ZLDPFBanner chart's image
Celldex Therapeutics
Price$26.85
Change+$0.38 (+1.44%)
Volume$499
Capitalization1.76B
Zealand Pharma A/S
Price$75.00
Change-$2.42 (-3.13%)
Volume$291
Capitalization5.4B
CLDX vs ZLDPF Comparison Chart in %
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLDPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDX vs. ZLDPF commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a Hold and ZLDPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (CLDX: $26.46 vs. ZLDPF: $75.00)
Brand notoriety: CLDX and ZLDPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 70% vs. ZLDPF: 60%
Market capitalization -- CLDX: $1.76B vs. ZLDPF: $5.4B
CLDX [@Biotechnology] is valued at $1.76B. ZLDPF’s [@Biotechnology] market capitalization is $5.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileZLDPF’s FA Score has 2 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • ZLDPF’s FA Score: 2 green, 3 red.
According to our system of comparison, ZLDPF is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 3 TA indicator(s) are bullish while ZLDPF’s TA Score has 3 bullish TA indicator(s).

  • CLDX’s TA Score: 3 bullish, 3 bearish.
  • ZLDPF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than ZLDPF.

Price Growth

CLDX (@Biotechnology) experienced а +0.92% price change this week, while ZLDPF (@Biotechnology) price change was -5.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.44%. For the same industry, the average monthly price growth was +17.42%, and the average quarterly price growth was +81.94%.

Reported Earning Dates

CLDX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZLDPF($5.4B) has a higher market cap than CLDX($1.76B). CLDX YTD gains are higher at: 4.709 vs. ZLDPF (-26.729). ZLDPF has higher annual earnings (EBITDA): 7.27B vs. CLDX (-231.4M). ZLDPF has more cash in the bank: 16.6B vs. CLDX (630M). CLDX has less debt than ZLDPF: CLDX (3.03M) vs ZLDPF (397M). ZLDPF has higher revenues than CLDX: ZLDPF (9.11B) vs CLDX (5.79M).
CLDXZLDPFCLDX / ZLDPF
Capitalization1.76B5.4B33%
EBITDA-231.4M7.27B-3%
Gain YTD4.709-26.729-18%
P/E RatioN/A5.20-
Revenue5.79M9.11B0%
Total Cash630M16.6B4%
Total Debt3.03M397M1%
FUNDAMENTALS RATINGS
CLDX vs ZLDPF: Fundamental Ratings
CLDX
ZLDPF
OUTLOOK RATING
1..100
1184
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
45
Fair valued
PROFIT vs RISK RATING
1..100
7369
SMR RATING
1..100
9719
PRICE GROWTH RATING
1..100
4445
P/E GROWTH RATING
1..100
10017
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZLDPF's Valuation (45) in the null industry is in the same range as CLDX (55) in the Biotechnology industry. This means that ZLDPF’s stock grew similarly to CLDX’s over the last 12 months.

ZLDPF's Profit vs Risk Rating (69) in the null industry is in the same range as CLDX (73) in the Biotechnology industry. This means that ZLDPF’s stock grew similarly to CLDX’s over the last 12 months.

ZLDPF's SMR Rating (19) in the null industry is significantly better than the same rating for CLDX (97) in the Biotechnology industry. This means that ZLDPF’s stock grew significantly faster than CLDX’s over the last 12 months.

CLDX's Price Growth Rating (44) in the Biotechnology industry is in the same range as ZLDPF (45) in the null industry. This means that CLDX’s stock grew similarly to ZLDPF’s over the last 12 months.

ZLDPF's P/E Growth Rating (17) in the null industry is significantly better than the same rating for CLDX (100) in the Biotechnology industry. This means that ZLDPF’s stock grew significantly faster than CLDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLDXZLDPF
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
48%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
62%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
67%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
59%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
60%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 15 days ago
74%
Declines
ODDS (%)
Bearish Trend 10 days ago
79%
Bearish Trend 25 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
65%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLDPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DDM106.520.95
+0.90%
ProShares Ultra Dow30
DJIA21.910.07
+0.32%
Global X Dow 30 Covered Call ETF
STHH57.82N/A
N/A
STMICROELECTRONICS NV ADRHEDGED STHH
PJIO63.62-0.23
-0.36%
PGIM Jennison International Opps ETF
HODL31.86-0.91
-2.78%
VanEck Bitcoin ETF

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-2.47%
BEAM - CLDX
54%
Loosely correlated
+0.12%
XNCR - CLDX
52%
Loosely correlated
-11.03%
RVMD - CLDX
51%
Loosely correlated
-2.56%
ARCT - CLDX
51%
Loosely correlated
+9.44%
VRDN - CLDX
51%
Loosely correlated
-2.81%
More

ZLDPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLDPF has been loosely correlated with KRYS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLDPF jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLDPF
1D Price
Change %
ZLDPF100%
-3.13%
KRYS - ZLDPF
46%
Loosely correlated
+1.79%
CLDX - ZLDPF
30%
Poorly correlated
-2.47%
NERV - ZLDPF
22%
Poorly correlated
+0.38%
SNDX - ZLDPF
22%
Poorly correlated
+0.72%
MIST - ZLDPF
22%
Poorly correlated
+2.76%
More